ethyl 13-cyanotridecanote | 36665-53-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 13-cyanotridecanote
• 英文别名: Ethyl 13-cyanotridecanoate
• CAS: 36665-53-9
• 化学式: C₁₆H₂₉NO₂
• 分子量: 267.412
• InChiKey: ZQOVMCBGNXZXTD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  19
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  50.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 13-cyanotridecanote 在 sodium tetrahydroborate 、 nickel(II) chloride hexahydrate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 4.0h， 生成 ethyl 14-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)tetradecanoate
  参考文献：
  名称：

  碳链长度通过线粒体靶向芳基尿素脂肪酸来调节MDA-MB-231乳腺癌细胞杀伤机制。

  摘要：

  靶向肿瘤细胞线粒体可以产生新型抗癌药。我们设计了一种芳基脲脂肪酸（1 g； 16（{[4-氯-3-（三氟甲基）苯基]氨基甲酰基}氨基）十六烷酸）破坏线粒体并降低MDA-MB-231乳腺癌细胞的活力。为了优化芳基脲，本研究评估了1 g含10-17个碳原子之间烷基链的类似物的线粒体靶向性。使用染料JC-1，C12-C17类似物可有效破坏线粒体膜电位（IC50为3.5±1.2至7.6±1.1μM）并破坏ATP的产生；较短的类似物活性较低。7-氨基放线菌素D / annexin V染色和流式细胞仪显示这些试剂在不同程度上激活了坏死和细胞凋亡的杀伤机制（7-氨基放线菌素D / annexin V染色比为4.3-6.0）。的确，1 g及其C17类似物分别优先激活坏死和凋亡（比率2.1和16）。综上所述，烷基链长是芳基脲对线粒体靶向的决定因素，可以改变以开发出以调节方式激活细胞凋亡或坏死的类似物。

  DOI：

  10.1002/cmdc.201900577
• 作为产物：
  描述：

  7-溴庚酸 在 [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl) palladium(II) dichloride 、 乙酰氯 、 lithium bromide 作用下， 以 四氢呋喃 、 N-甲基吡咯烷酮 为溶剂， 反应 22.0h， 生成 ethyl 13-cyanotridecanote
  参考文献：
  名称：

  Antiproliferative and Antimigratory Actions of Synthetic Long Chain n-3 Monounsaturated Fatty Acids in Breast Cancer Cells That Overexpress Cyclooxygenase-2

  摘要：

  Cyclooxygenase-2 (COX-2) is overexpressed in many human cancers and converts the n-6 polyunsaturated fatty acid (PUFA) arachidonic acid to prostaglandin E-2 (PGE(2)), which drives tumorigenesis; in contrast, n-3 PUFA inhibit tumorigenesis. We tested the hypothesis that these antitumor actions of n-3 PUFA may involve the n-3 olefinic bond. n-3 Monounsaturated fatty acids (MUFAs) of chain length C16-C22 were synthesized and evaluated in MDA-MB-468 breast cancer cells that stably overexpressed COX-2 (MDA-COX-2 cells). Longer chain (C19-C22) n-3 MUFAs inhibited proliferation, activated apoptosis, decreased PGE2 formation, and decreased cell invasion; C16-C18 analogues were less active. Molecular modeling showed that interactions of Arg120, Tyr355, and several hydrophobic amino acid residues in the COX-2 active site with C19-C22 MUFA analogues were favored. Thus, longer-chain n-3 MUFAs may be prototypes of novel anticancer agents that decrease the formation of PGE2 in tumor cells that contain high levels of COX-2.

  DOI：

  10.1021/jm300673z

文献信息

• Giese, Bernd; Kretzschmar, Gerhard, Angewandte Chemie, 1981, vol. 93, # 11, p. 1015 - 1016
  作者：Giese, Bernd、Kretzschmar, Gerhard

  DOI：——

  日期：——
• Antiproliferative and Antimigratory Actions of Synthetic Long Chain n-3 Monounsaturated Fatty Acids in Breast Cancer Cells That Overexpress Cyclooxygenase-2
  作者：Pei H. Cui、Tristan Rawling、Kirsi Bourget、Terry Kim、Colin C. Duke、Munikumar R. Doddareddy、David E. Hibbs、Fanfan Zhou、Bruce N. Tattam、Nenad Petrovic、Michael Murray

  DOI：10.1021/jm300673z

  日期：2012.8.23

  Cyclooxygenase-2 (COX-2) is overexpressed in many human cancers and converts the n-6 polyunsaturated fatty acid (PUFA) arachidonic acid to prostaglandin E-2 (PGE(2)), which drives tumorigenesis; in contrast, n-3 PUFA inhibit tumorigenesis. We tested the hypothesis that these antitumor actions of n-3 PUFA may involve the n-3 olefinic bond. n-3 Monounsaturated fatty acids (MUFAs) of chain length C16-C22 were synthesized and evaluated in MDA-MB-468 breast cancer cells that stably overexpressed COX-2 (MDA-COX-2 cells). Longer chain (C19-C22) n-3 MUFAs inhibited proliferation, activated apoptosis, decreased PGE2 formation, and decreased cell invasion; C16-C18 analogues were less active. Molecular modeling showed that interactions of Arg120, Tyr355, and several hydrophobic amino acid residues in the COX-2 active site with C19-C22 MUFA analogues were favored. Thus, longer-chain n-3 MUFAs may be prototypes of novel anticancer agents that decrease the formation of PGE2 in tumor cells that contain high levels of COX-2.
• Carbon Chain Length Modulates MDA‐MB‐231 Breast Cancer Cell Killing Mechanisms by Mitochondrially Targeted Aryl−Urea Fatty Acids
  作者：Michael Murray、Ariane Roseblade、Yongjuan Chen、Kirsi Bourget、Tristan Rawling

  DOI：10.1002/cmdc.201900577

  日期：2020.1.17

  anticancer agents. We designed an aryl-urea fatty acid (1 g; 16([4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)hexadecanoic acid) that disrupted the mitochondrion and decreased MDA-MB-231 breast cancer cell viability. To optimize the aryl-ureas the present study evaluated mitochondrial targeting by 1 g analogues containing alkyl chains between 10-17 carbons. Using the dye JC-1, the C12-C17 analogues

  靶向肿瘤细胞线粒体可以产生新型抗癌药。我们设计了一种芳基脲脂肪酸（1 g； 16（[4-氯-3-（三氟甲基）苯基]氨基甲酰基}氨基）十六烷酸）破坏线粒体并降低MDA-MB-231乳腺癌细胞的活力。为了优化芳基脲，本研究评估了1 g含10-17个碳原子之间烷基链的类似物的线粒体靶向性。使用染料JC-1，C12-C17类似物可有效破坏线粒体膜电位（IC50为3.5±1.2至7.6±1.1μM）并破坏ATP的产生；较短的类似物活性较低。7-氨基放线菌素D / annexin V染色和流式细胞仪显示这些试剂在不同程度上激活了坏死和细胞凋亡的杀伤机制（7-氨基放线菌素D / annexin V染色比为4.3-6.0）。的确，1 g及其C17类似物分别优先激活坏死和凋亡（比率2.1和16）。综上所述，烷基链长是芳基脲对线粒体靶向的决定因素，可以改变以开发出以调节方式激活细胞凋亡或坏死的类似物。